Regenxbio presents positive results from phase I/IIa trial of RGX-314
15 Oct 2019 //
PHARMABIZ
Early snapshot of Adverum`s eye gene therapy sparks concern about vision loss
13 Sep 2019 //
ENDPTS
15 Oct 2019 //
PHARMABIZ
13 Sep 2019 //
ENDPTS